stockrow
Friday 6 November 2026
Export ARDT’s income statement to Excel — free account
Ardent Health, Inc.
ARDT Healthcare Medical Care Facilities
Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024.
- Revenue
- +3.05%
- EPS
- +288.2%
- Free cash flow
- −23.5%
- Total debt
- −0.72%
Quarter to September 2026, against a year earlier
15.78
2.79
+21.48%
Follow ARDT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 4 | 5 |
| 8.47% | 8.14% | 4.61% | 8.55% | ||
| 2.65% | 2.64% | 1.52% | 2.78% | ||
ROIC |
9.80% | 9.49% | 7.59% | 0.00% | |
Return on Tangible Assets |
6.97% | 6.74% | 3.91% | 12.68% | |
Average Days of Receivables |
39.60 | 38.95 | 39.65 | 37.43 | |
Free Cash Flow per Share |
1.84 | 1.54 | 2.15 | 2.01 | |
Free Cash Flow |
258.61 | 217.99 | 304.76 | 282.30 | |
Capital Expenditures |
(211.90) | (217.08) | (209.56) | (199.57) | |
| Other line items | |||||
Cash ROIC |
7.40% | 6.31% | 8.53% | 7.73% | |
Accounts Receivable Turnover |
8.85 | 8.79 | 8.81 | 9.28 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.20) | (0.20) | (0.19) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
78.00% | 77.51% | 78.48% | 0.00% | |
Share Based Compensation of Revenue |
0.62% | 0.61% | 0.56% | 0.52% | |
Interest Coverage |
5.90 | 6.38 | 5.05 | 0.00 | |
Operating CF/Net income |
3.46 | 3.24 | 6.57 | 3.30 | |
Depreciation/Fixed assets |
0.17 | 0.18 | 0.18 | 0.00 | |
Capex/Depreciation |
(1.32) | (1.30) | (1.25) | (1.18) | |
Revenue per Share |
44.93 | 45.51 | 45.21 | 45.91 | |
Operating CF per Share |
3.34 | 3.08 | 3.63 | 3.43 | |
Capex per Share |
(1.51) | (1.54) | (1.48) | (1.42) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026